Desilvio v. LION BIOTECHNOLOGIES, INC. et al
ORDER RE: PROPOSED LEAD PLAINTIFFS (Illston, Susan) (Filed on 7/7/2017)
UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA
ORDER RE: PROPOSED LEAD
LION BIOTECHNOLOGIES, INC., et al.,
United States District Court
Northern District of California
Case No. 17-cv-02086-SI
The Court is in receipt of three competing motions to appoint lead plaintiff and lead
counsel in this case. The three movants for lead plaintiff are: (1) Kimberly Colautti and Michele
Rosati (together, “Colautti and Rosati”), Dkt. No. 10; (2) Jay Rabkin (“Rabkin”), Dkt. No. 13; and
(3) Su Yee Lynn Ho, Sriram Sundareswaran, Manfred E. Strauch, and Kevin Fong (together, the
“Lion Investor Group” or “LIG”), Dkt. No. 20.
Each movant has filed the necessary certification, see Dkt. Nos. 11-1, 14-1, 21-2.
However, the information provided there is skeletal. Prior to decision on the motions, the Court
requires more information about the various movants. Accordingly, each individual movant is
hereby ordered to file a brief declaration on or before July 14, 2017, setting forth: (i) each
individual’s city and state of residence; (ii) each individual’s occupation; (iii) whether and to what
extent the moving individuals are familiar with one another; (iv) how each individual came to
retain his/her respective lawyer(s); and (v) the general nature of each individual’s investment in
Lion Biotechnologies, Inc.
IT IS SO ORDERED.
Dated: July 7, 2017
United States District Judge
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?